• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Massive acute ischemic stroke after Bothrops spp. envenomation in southwestern Colombia: Case report and literature review
We present here the case of a 50-year-old male with no comorbidities referred from a rural area in southwest Colombia with a Bothrops spp. snakebite on the left hand. On admission, the patient presented with a deterioration of consciousness and required mechanical ventilation assistance. The MRI showed multiple ischemic areas in the bilateral frontaltemporal and occipital regions. Two months later, the patient had a favorable resolution, although central paresis in the III and VI cranial nerves and positive Babinski's sign persisted. As already mentioned, the pathophysiology of ischemic stroke due to snakebite is complex b...
Source: Biomedica : Revista del Instituto Nacional de Salud - April 26, 2022 Category: International Medicine & Public Health Authors: Viviana Alexandra Mart ínez-Villota Paulo Francisco Mera-Mart ínez Jos é Darío Portillo-Miño Source Type: research

Cost-Effectiveness of Bariatric Surgery Compared With Nonsurgical Treatment in People With Obesity and Comorbidity in Colombia
ConclusionThe current study provides evidence that bariatric surgery is a cost-effective alternative among some cohorts in the Colombian setting. For obese patients with sleep apnea or diabetes, bariatric surgery is a recommendable alternative (dominant and cost-effective, respectively) for the Colombian healthcare system.
Source: Value in Health Regional Issues - May 11, 2019 Category: International Medicine & Public Health Source Type: research

Cost-Efectiveness Of Dabigatran In Non Valvular Atrial Fibrillation In Colombia
Atrial fibrillation (AF) is the most common cardiac rhythm disorder; it increases stroke risk 5 to 6 times. Prevalence in Colombia has been estimated in 3.6% in population age 60 or over (some 180 000 potential patients). The aim of this study was to estimate cost-effectiveness of dabigatran 110 mg and 150 mg BID as a therapy for non valvular AF in Colombian population.
Source: Value in Health - May 1, 2015 Category: Global & Universal Authors: J.J. Triana, C. Castañeda-Cardona, L. Parada, D. Rosselli Source Type: research

Pages: 1  2  3  4  5